Geron Corp (NASDAQ: GERN) kicked off on Monday, up 6.30% from the previous trading day, before settling in for the closing price of $1.27. Over the past 52 weeks, GERN has traded in a range of $1.17-$5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 6535.01%. While this was happening, its average annual earnings per share was recorded 60.03%. With a float of $597.84 million, this company’s outstanding shares have now reached $606.39 million.
Let’s determine the extent of company efficiency that accounts for 229 employees. In terms of profitability, gross margin is 97.97%, operating margin of -225.64%, and the pretax margin is -226.73%.
Geron Corp (GERN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Geron Corp is 6.13%, while institutional ownership is 76.62%. The most recent insider transaction that took place on Feb 27 ’25, was worth 24,150. In this transaction EVP, Chief Legal Officer of this company bought 15,000 shares at a rate of $1.61, taking the stock ownership to the 26,682 shares. Before that another transaction happened on Feb 27 ’25, when Company’s Chairman, President and CEO bought 12,500 for $1.76, making the entire transaction worth $22,062. This insider now owns 12,500 shares in total.
Geron Corp (GERN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 60.03% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Take a look at Geron Corp’s (GERN) current performance indicators. Last quarter, stock had a quick ratio of 5.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.27, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.01 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Looking closely at Geron Corp (NASDAQ: GERN), its last 5-days average volume was 12.75 million, which is a drop from its year-to-date volume of 14.79 million. As of the previous 9 days, the stock’s Stochastic %D was 45.24%. Additionally, its Average True Range was 0.13.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 5.93%, which indicates a significant decrease from 40.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 96.92% in the past 14 days, which was higher than the 84.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8320, while its 200-day Moving Average is $3.5168. However, in the short run, Geron Corp’s stock first resistance to watch stands at $1.4300. Second resistance stands at $1.5100. The third major resistance level sits at $1.5900. If the price goes on to break the first support level at $1.2700, it is likely to go to the next support level at $1.1900. Now, if the price goes above the second support level, the third support stands at $1.1100.
Geron Corp (NASDAQ: GERN) Key Stats
The company with the Market Capitalisation of 859.83 million has total of 636,913K Shares Outstanding. Its annual sales at the moment are 76,990 K in contrast with the sum of -174,570 K annual income. Company’s last quarter sales were recorded 47,540 K and last quarter income was -25,350 K.
